{"id":2020,"date":"2020-11-05T10:43:42","date_gmt":"2020-11-05T18:43:42","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=2020"},"modified":"2020-11-06T10:44:29","modified_gmt":"2020-11-06T18:44:29","slug":"lack-of-antibodies-to-sars-cov-2-in-a-large-cohort-of-previously-infected-persons","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/11\/05\/lack-of-antibodies-to-sars-cov-2-in-a-large-cohort-of-previously-infected-persons\/","title":{"rendered":"Lack of Antibodies to SARS-CoV-2 in a Large Cohort of Previously Infected Persons"},"content":{"rendered":"<ul>\n<li>A total of 6.3% of 2,547 healthcare workers and first responders in the New York City and Detroit metropolitan areas with previous confirmed SARS-CoV-2 infection were seronegative. Among symptomatic persons, the proportion seronegative was largely stable between 2 weeks and 90 days following symptom onset. The proportion seronegative ranged from 0% among 79 persons previously hospitalized to 11% among 308 persons with asymptomatic infections. Additionally, immunosuppressive medications, non-Hispanic white race\/ethnicity, and obesity were associated with lack of antibodies.<\/li>\n<\/ul>\n<p>Petersen et al. (Nov 4, 2020). Lack of Antibodies to SARS-CoV-2 in a Large Cohort of Previously Infected Persons. Clinical Infectious Diseases. <a href=\"https:\/\/doi.org\/10.1093\/cid\/ciaa1685\">https:\/\/doi.org\/10.1093\/cid\/ciaa1685<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A total of 6.3% of 2,547 healthcare workers and first responders in the New York City and Detroit metropolitan areas with previous confirmed SARS-CoV-2 infection were seronegative. Among symptomatic persons, the proportion seronegative was largely stable between 2 weeks and 90 days following symptom onset. The proportion seronegative ranged from 0% among 79 persons previously&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/11\/05\/lack-of-antibodies-to-sars-cov-2-in-a-large-cohort-of-previously-infected-persons\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[67,32],"topic":[31],"class_list":["post-2020","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-antibodies","tag-immunity","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=2020"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2020\/revisions"}],"predecessor-version":[{"id":2021,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2020\/revisions\/2021"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=2020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=2020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=2020"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=2020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}